Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokes

BackgroundIn patients with non-cardio-embolic stroke, atorvastatin 80 mg/day reduced the relative risk of recurrent stroke by 16%, and a post hoc analysis showed that achieving an LDL-c of less tha...